Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group

NCT05231135 is registered in ClinicalTrials.gov with Rotkreuzklinikum München gGmbH as lead sponsor.

NCT NCT05231135
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05231135 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics, Treatment and Outcomes of HIV-infected Patients With Malignant Lymphoma: A Registry Study of the European Hematology Association (EHA) Lymphoma Group
Lead sponsor
Rotkreuzklinikum München gGmbH
Phase
Observational
Overall status
Recruiting
Start date
August 25, 2021
Completion date
August 31, 2029
Enrollment
300 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

aids related lymphoma, hiv related lymphoma